期刊文献+

血清HBsAg阳性患者肝癌及癌旁组织中P^(53)和K-ras基因突变及其相互关系 被引量:3

下载PDF
导出
摘要 应用PCR-SSCP方法对24例血清HBsAg(+)患者肝癌及癌旁组织中P53和K-ras基因突变进行了检测。肝癌组织中P53基因突变率为33%,K-ras基因突变率为25%,癌旁正常组织中无P53和K-ras基因突变,癌旁硬化组织中K-ras突变为15%,无P53基因突变。在有HBV的肝场组织中P53基因突变率为100%,K-ras突变率为67%,提示P53与K-ras基因突变机制与HBV感染有一定关系。P53与K-ras突变无相关性。后者可能是肝癌形成过程中的早期行为,前者与肝癌的发展、进行有关。
出处 《临床肝胆病杂志》 CAS 北大核心 1998年第1期36-38,共3页 Journal of Clinical Hepatology
  • 相关文献

参考文献4

  • 1Stephen J. U,Anderson C. W. Mener W. E,et al. The p^53 tumor suppressor protein, a molelator of cell proliferation. J Bio. Chem, 1992:267:15259.
  • 2Michael B. J. Molecular theme in oncogenesis, Cell,1991,64:235.
  • 3Hsu I. C,Metcalf R. A,Sun t. ,et al. Mutationnal hotspot in the P^53 gene in human heptacellular carcinomas. Nature, 1991:350(6317) :427.
  • 4Kim C. M ,Kuike K ,Saito I,et al. HBx gerre of haptitis B virus induces liver cancer in transgenic mice. Nature,1991,351:317.

同被引文献58

  • 1李进,刘妍,戴久增,徐东平,张玲霞.乙型肝炎病毒X蛋白转录抑制抑癌基因p53表达的研究[J].中华实验和临床病毒学杂志,2006,20(1):26-29. 被引量:6
  • 2Zhong-Fu Zhao,Hui Yang,De-Wu Han,Long-Feng Zhao,Guo-Ying Zhang,Yun Zhang,Ming-She Liu.Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15[J].World Journal of Gastroenterology,2006,12(37):6046-6049. 被引量:14
  • 3Joachim Lupberger,Eberhard Hildt.Hepatitis B virus-induced oncogenesis[J].World Journal of Gastroenterology,2007,13(1):74-81. 被引量:57
  • 4Yong-Song Guan Zi La Lin Yang Qing He Ping Li.p53 gene in treatment of hepatic carcinoma:Status quo[J].World Journal of Gastroenterology,2007,13(7):985-992. 被引量:13
  • 5Carlton LS, Diana PE, Dana M, et al. Past, present and future targets for immunotherapy in ovarian cancer [J]. Immunotherapy, 2014, 6(12) : 1279-1298.
  • 6Odunsi K, Matsuzaki J, Karbach J, et al. Efficacy of vaccination with recombinant vaccinia and fowlpox vec- tors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients [ J ]. Proc Natl Acad, USA, 2012, 109(15) : 5797-5802.
  • 7Rapoport AP, Stadtmaner EA, Binder-Scholl GK, et al. NY-ESO-l-specific TCR-engineered T ceils medi- ate sustained antigen-specific antitumor effects in mye- loma[J]. Nat Med, 2015, 21(18): 914-921.
  • 8Peng YH, Xu YW, Qin SQ, et al. Combination of an- toantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopha- ryngeal carcinoma [ J ]. Oncol Left, 2014, 8 ( 3 ) : 1093-1102.
  • 9Li M, Shi H, Mu Y, et al. Effective inhibition of mel- anoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-l-alum-polysaccharide-HH2 [J]. Mol Cancer, 2014, 13: 179.
  • 10Dos SL, Galavo-Filho B, Faria PC, et al. Blockade of CTLA-4 promotes the development of effector CDs+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1 [J]. Cancer Immunol Immunother, 2015, 64 (3) : 311-323.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部